Neuphoria Therapeutics Inc

Neuphoria Therapeutics Inc (NEUP) SEC filings

Neuphoria Therapeutics Inc (NEUP) SEC filings — 10-K, 10-Q, 8-K, and Form 4 as cached from EDGAR. When an exhibit lands, this page shows the headline, the numbers, and why it matters.

Those exhibit numbers sit next to the income-statement cache: Latest reported NEUP revenue for 2025-06-30 was $15.6M. Net income was -$369.6K. NEUP currently screens at market cap $23.6M. The NEUP filings page is the source view; the stock page is the research view.

EDGAR remains the official archive. Lician caches 8-K exhibits so you can read what Neuphoria Therapeutics Inc said without waiting on a live EDGAR scrape. Item 2.02 is the earnings exhibit — this page prefers EX-99.1 revenue, growth, EPS, and guidance over a form-type label. Form 4 insider prints stay on the same ticker timeline.

0

10-K

0

10-Q

2

8-K

0

Form 4

Recent filings

8-K1.015.017.01

8-K exhibit

EDGAR
8-K1.011.029.01

8-K exhibit

EDGAR

EDGAR is the official archive. Browse all NEUP filings.

Frequently asked questions

What did NEUP just say?

NEUP cached filings are listed below. Open the latest 8-K exhibit for the company’s own words.

Where are NEUP SEC filings?

2 cached filings are on this page. EDGAR remains the official archive (CIK 0001191070).

What is an 8-K Item 2.02?

Item 2.02 is the earnings exhibit. Lician reads EX-99.1 for revenue, growth, EPS, and guidance — not a form-type label.